- Report
- August 2022
- 135 Pages
Global
From €4737EUR$4,750USD£3,957GBP
- Report
- August 2022
- 120 Pages
Global
From €4737EUR$4,750USD£3,957GBP
- Report
- January 2022
- 111 Pages
Global
From €4737EUR$4,750USD£3,957GBP
- Report
- January 2022
- 110 Pages
Global
From €4737EUR$4,750USD£3,957GBP
- Report
- January 2022
- 117 Pages
Global
From €4737EUR$4,750USD£3,957GBP
- Drug Pipelines
- January 2019
- 163 Pages
Global
From €21941EUR$22,000USD£18,327GBP
- Report
- January 2024
- 200 Pages
Global
From €4139EUR$4,150USD£3,457GBP
- Report
- November 2023
- 165 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Report
- January 2022
- 120 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Report
- January 2022
- 120 Pages
Global
From €2493EUR$2,500USD£2,083GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1247EUR$1,250USD£1,041GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1496EUR$1,500USD£1,250GBP
- Report
- July 2022
- 100 Pages
Global
From €2743EUR$2,750USD£2,291GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €2244EUR$2,250USD£1,874GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €2244EUR$2,250USD£1,874GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €2244EUR$2,250USD£1,874GBP
- Report
- January 2022
- 60 Pages
Global
From €3939EUR$3,950USD£3,290GBP
- Report
- January 2022
- 60 Pages
Global
From €3939EUR$3,950USD£3,290GBP
- Report
- January 2022
- 60 Pages
Global
From €3939EUR$3,950USD£3,290GBP
- Report
- January 2022
- 60 Pages
Global
From €3939EUR$3,950USD£3,290GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more